Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292505843> ?p ?o ?g. }
- W4292505843 endingPage "4471" @default.
- W4292505843 startingPage "4455" @default.
- W4292505843 abstract "Abstract Non‐Small Cell Lung Carcinoma (NSCLC) remains a leading cause of cancer death. Resistance to therapy is a significant problem, highlighting the need to find new ways of sensitising tumour cells to therapeutic agents. βIII‐tubulin is associated with aggressive tumours and chemotherapy resistance in a range of cancers including NSCLC. βIII‐tubulin expression has been shown to impact kinase signalling in NSCLC cells. Here, we sought to exploit this interaction by identifying co‐activity between βIII‐tubulin suppression and small‐molecule kinase inhibitors. To achieve this, a forced‐genetics approach combined with a high‐throughput drug screen was used. We show that activity of the multi‐kinase inhibitor Amuvatinib (MP‐470) is enhanced by βIII‐tubulin suppression in independent NSCLC cell lines. We also show that this compound significantly inhibits cell proliferation among βIII‐tubulin knockdown cells expressing the receptor tyrosine kinase c‐Met. Together, our results highlight that βIII‐tubulin suppression combined with targeting specific receptor tyrosine kinases may represent a novel therapeutic approach for otherwise difficult‐to‐treat lung carcinomas." @default.
- W4292505843 created "2022-08-21" @default.
- W4292505843 creator A5008322025 @default.
- W4292505843 creator A5013588929 @default.
- W4292505843 creator A5017575360 @default.
- W4292505843 creator A5020258044 @default.
- W4292505843 creator A5026784302 @default.
- W4292505843 creator A5050255687 @default.
- W4292505843 creator A5069976894 @default.
- W4292505843 creator A5076707829 @default.
- W4292505843 creator A5085362634 @default.
- W4292505843 creator A5088524824 @default.
- W4292505843 creator A5090648552 @default.
- W4292505843 date "2022-08-10" @default.
- W4292505843 modified "2023-10-15" @default.
- W4292505843 title "βIII‐tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c‐Met positive non‐small cell lung cancer cells" @default.
- W4292505843 cites W1552550535 @default.
- W4292505843 cites W1691796058 @default.
- W4292505843 cites W1743462958 @default.
- W4292505843 cites W1780086376 @default.
- W4292505843 cites W1968075437 @default.
- W4292505843 cites W1971745560 @default.
- W4292505843 cites W1971914762 @default.
- W4292505843 cites W1974903851 @default.
- W4292505843 cites W1982987246 @default.
- W4292505843 cites W1996323392 @default.
- W4292505843 cites W1998038367 @default.
- W4292505843 cites W2000744297 @default.
- W4292505843 cites W2007917102 @default.
- W4292505843 cites W2011826559 @default.
- W4292505843 cites W2033949372 @default.
- W4292505843 cites W2037838528 @default.
- W4292505843 cites W2052750950 @default.
- W4292505843 cites W2055631278 @default.
- W4292505843 cites W2060797544 @default.
- W4292505843 cites W2062289724 @default.
- W4292505843 cites W2073667620 @default.
- W4292505843 cites W2074161778 @default.
- W4292505843 cites W2079216025 @default.
- W4292505843 cites W2087064752 @default.
- W4292505843 cites W2104366432 @default.
- W4292505843 cites W2106787323 @default.
- W4292505843 cites W2110468894 @default.
- W4292505843 cites W2115843648 @default.
- W4292505843 cites W2117692326 @default.
- W4292505843 cites W2118920851 @default.
- W4292505843 cites W2128141811 @default.
- W4292505843 cites W2139131914 @default.
- W4292505843 cites W2146012957 @default.
- W4292505843 cites W2149882720 @default.
- W4292505843 cites W2159712725 @default.
- W4292505843 cites W2161269127 @default.
- W4292505843 cites W2167766673 @default.
- W4292505843 cites W2169668454 @default.
- W4292505843 cites W2316339075 @default.
- W4292505843 cites W2403950404 @default.
- W4292505843 cites W2420859550 @default.
- W4292505843 cites W2503201176 @default.
- W4292505843 cites W2523269553 @default.
- W4292505843 cites W2537306989 @default.
- W4292505843 cites W2561489464 @default.
- W4292505843 cites W2613112008 @default.
- W4292505843 cites W2725369123 @default.
- W4292505843 cites W2743423113 @default.
- W4292505843 cites W2776647540 @default.
- W4292505843 cites W2794930605 @default.
- W4292505843 cites W2802503852 @default.
- W4292505843 cites W3013637791 @default.
- W4292505843 cites W3121560287 @default.
- W4292505843 cites W3163101457 @default.
- W4292505843 cites W3173362811 @default.
- W4292505843 cites W4224050057 @default.
- W4292505843 cites W4225012629 @default.
- W4292505843 cites W4247904703 @default.
- W4292505843 cites W4292505843 @default.
- W4292505843 doi "https://doi.org/10.1002/cam4.5128" @default.
- W4292505843 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35946957" @default.
- W4292505843 hasPublicationYear "2022" @default.
- W4292505843 type Work @default.
- W4292505843 citedByCount "1" @default.
- W4292505843 countsByYear W42925058432022 @default.
- W4292505843 crossrefType "journal-article" @default.
- W4292505843 hasAuthorship W4292505843A5008322025 @default.
- W4292505843 hasAuthorship W4292505843A5013588929 @default.
- W4292505843 hasAuthorship W4292505843A5017575360 @default.
- W4292505843 hasAuthorship W4292505843A5020258044 @default.
- W4292505843 hasAuthorship W4292505843A5026784302 @default.
- W4292505843 hasAuthorship W4292505843A5050255687 @default.
- W4292505843 hasAuthorship W4292505843A5069976894 @default.
- W4292505843 hasAuthorship W4292505843A5076707829 @default.
- W4292505843 hasAuthorship W4292505843A5085362634 @default.
- W4292505843 hasAuthorship W4292505843A5088524824 @default.
- W4292505843 hasAuthorship W4292505843A5090648552 @default.
- W4292505843 hasBestOaLocation W42925058432 @default.
- W4292505843 hasConcept C101544691 @default.
- W4292505843 hasConcept C121608353 @default.
- W4292505843 hasConcept C126322002 @default.
- W4292505843 hasConcept C1491633281 @default.